Arş. Gör. Dr. CEREN HANGÜL MADEN

Yayın Ağı

Makaleler 14

1. MYH2 as a Potential Modifier of Clinical Severity in Facioscapulohumeral Muscular Dystrophy

Hangül Maden C.

JOURNAL OF MOLECULAR NEUROSCIENCE , cilt.76, ss.1, 2026 (SCI-Expanded, Scopus)

2. Gut Microbiota and Short-Chain Fatty Acid Profiles in Facioscapulohumeral Dystrophy: Associations with Epigenetic Alterations

Hangul C., KOYUNCU ÖZYURT Ö., Baldi S., ÇOLAK D., Tokta O., Pekcan T., et al.

Canadian Journal of Neurological Sciences , cilt.53, sa.1, ss.11-22, 2026 (SCI-Expanded, Scopus)

3. Chromosome 4q D4Z4 contraction status in Turkish patients with facioscapulohumeral muscular dystrophy

Hangül Maden C., Şahan Ö. B., Karaüzüm S., Sauer E., Uysal H., Koç F.

CUKUROVA MEDICAL JOURNAL , cilt.50, sa.3, ss.702-711, 2025 (ESCI, TRDizin) Sürdürülebilir Kalkınma

4. Quantitative Three-dimensional Scanning of Facial Movements in Facioscapulohumeral Dystrophy

Hangül Maden C.

Neurological Sciences and Neurophysiology , cilt.42, sa.2, ss.48-55, 2025 (SCI-Expanded)

5. Bibliometric analysis on trends and future direction of facioscapulohumeral muscular dystrophy research

YARDİBİ F., Hangül C., Chaomei C.

Turk Noroloji Dergisi , cilt.31, sa.3, ss.341-353, 2025 (ESCI)

6. Human Umbilical Vein Endothelial Cells Express the DUX4 Protein: A Basis for Further Vascular Research Human Umbilical Vein Endothelial Cells Express the DUX4 Protein: A Basis for Further Vascular Research

Hangul C., BAHAR D., Ekinci Ö., Tokta Ö., ÖZKUL Y., Karauzum S. B.

Turk patoloji dergisi , cilt.41, sa.3, ss.113-122, 2025 (ESCI)

7. Progesterone may be a regulator and B12 could be an indicator of the proximal D4Z4 repeat methylation status on 4q35ter

HANGÜL C., Ozcan F., Darbas S., Uysal H., KOÇ A. F., Berker Karauzum S.

Journal of Neurochemistry , cilt.168, sa.9, ss.3209-3220, 2024 (SCI-Expanded)

8. Analysis of DUX4 Expression in Bone Marrow and Re-Discussion of DUX4 Function in the Health and Disease.

Hangul C., Tokta O., Karauzum S. B., Akkaya B., Yildirim H., Kupesiz F., et al.

Turk patoloji dergisi , 2021 (ESCI)

9. Estradiol differentially regulates DUX4, beta-catenin and PAX3/PAX7 in primary myoblasts of facioscapulohumeral muscular dystrophy patients

HANGÜL C., ÇELİK E. G., KAYA H., EROĞLU O., UYSAL H., KARAÜZÜM S.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.46, sa.4, ss.435-444, 2021 (SCI-Expanded, Scopus, TRDizin)

10. Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals

HANGÜL C., Karaüzüm S. B., Akkol E. K., DEMİR DORA D., Çetin Z., Saygılı E. İ., et al.

Current neuropharmacology , cilt.19, sa.12, ss.2276-2295, 2021 (SCI-Expanded, Scopus)

11. The ratios of estradiol and progesterone to testosterone influence the severity of facioscapulohumeral muscular dystrophy

HANGÜL C., Bozkurt S., BİLGE U., ÖZDEM S., ALTUNBAŞ H., UYSAL H., et al.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , cilt.37, sa.4, ss.190-196, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

12. Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases

Aydin C., Ulas T., Hangül C., Yücel O. K., Iltar U., Salim O., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.36, sa.2, ss.284-291, 2020 (SCI-Expanded, Scopus)

13. A Novel Coincidence: Essential Thrombocythemia with Facioscapulohumeral Muscular Dystrophy

HANGÜL C., YÜCEL O. K., TOYLU A., UYSAL H., Karauzum S. B.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.4, ss.306-307, 2020 (SCI-Expanded, Scopus, TRDizin)

14. The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma

Hangül C., Yücel O. K., Akkaya B., Ündar L., Berker Karaüzüm S.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.36, ss.124-125, 2019 (SCI-Expanded, Scopus, TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 22

1. Chromosome 4q D4Z4 contraction status in Turkish patients with facioscapulohumeral muscular dystrophy

Hangül Maden C.

2026 International Research Congress on FSHD, Illinois, Amerika Birleşik Devletleri, 25 - 26 Haziran 2026, (Özet Bildiri)

2. Gut microbiota and short-chain fatty acid profiles in facioscapulohumeral dystrophy: associations with epigenetic alterations

Hangül Maden C.

European Human Genetics Conference, Gothenburg, İsveç, 13 - 16 Haziran 2026, ss.35, (Özet Bildiri)

3. Human Umbilical Vein Endothelial Cells Express the DUX4 protein: A basis for further vascular research

Hangül Maden C.

European Human Genetics Conference 2026, Gothenburg, İsveç, 13 - 16 Haziran 2026, ss.13, (Özet Bildiri)

4. FASYOSKAPULOHUMERAL DISTROFI HASTALARINDA BAĞIRSAK MIKROBIYOTASI VE KISA ZINCIRLI YAĞ ASIDI PROFILLERININ INCELENMESI

Hangül Maden C., Koyuncu Özyurt Ö., Baldi S., Çolak D., Tokta Ö., Pekcan T., et al.

8. ULUSAL KLİNİK MİKROBİYOLOJİ KONGRESİ, Antalya, Türkiye, 19 - 23 Kasım 2025, ss.71-72, (Özet Bildiri)

5. Progesterone may be a regulator and B12 could be an indicator of the proximal D4Z4 repeat methylation status on 4q35ter

Hangül Maden C.

31th Annual FSHD Society International Research Congress, Colorado, Amerika Birleşik Devletleri, Amsterdam, Hollanda, 12 - 13 Haziran 2025, (Yayınlanmadı)

6. “Interleukin 1 beta levels were significantly different in male FSHD patients”

Hangül C.

31th Annual FSHD Society International Research Congress, Colorado, Amerika Birleşik Devletleri, 13 - 14 Haziran 2024, ss.1, (Özet Bildiri)

7. Synonymous MYH9 mutation was identified in a FSHD family with thrombocyte number change: is it more than a coincidance?

Hangül C., Yücel O. K., Toylu A., Torun Özkan D., Uysal H., Çiftçi V., et al.

28. FSHD International Research Congress, Massachusetts, Amerika Birleşik Devletleri, 25 - 26 Haziran 2021, (Yayınlanmadı)

8. Synonymous MYH9 mutation was identified in a FSHD family with thrombocyte number change: is it more than a coincidence?

HANGÜL C., YÜCEL O. K., TOYLU A., UYSAL H., ÖZKAN D., ÇİFTÇİ V., et al.

28 th Annual FSHD Society International Research Congress, Türkiye, 24 - 25 Haziran 2021, (Özet Bildiri)

9. Novel coincidence: FSHD case with myeloproliferative disorder

Hangül C., Yücel O. K., Toylu A., Uysal H., Karaüzüm S.

27. FSHD International Research Congress, Maryland, Amerika Birleşik Devletleri, 25 - 26 Haziran 2020, (Özet Bildiri)

10. Investigation of the Effect of Estrogen on DUX4/ß-Katenin/PAX3-7 Protein Levels in Facioscapulohumeral Muscular Dystrophy (FSHD).

HANGÜL C.

2019 FSH Society International Research Congress, Marsilya, Fransa, 19 - 20 Haziran 2019, ss.73, (Tam Metin Bildiri)

11. Facioscapulohumeral Muscular Dystrophy (FSHD) has a Talk with Endocrinologic Parameters: Estradiol, Progesterone and Testosterone

HANGÜL C., ÖZSOY U., HİZAY A., BOZKURT S., BİLGE U., ÖZDEM S., et al.

FSH Society International Research Congress, 19 - 20 Haziran 2019, (Özet Bildiri)

12. ÖSTROJENİN FASİOSKAPULOHUMERAL MUSKÜLERDİSTROFİ (FSHD)’DE B-KATENİN, DUX4 VE PAX3/7DÜZEYLERİNE ETKİSİ

HANGÜL C., GÜVENİR ÇELİK E., KAYA ÇAKIR H., EROĞLU O., UYSAL H., KARAÜZÜM S.

54.Ulusal Nöroloji Kongresi Uluslararası katılımlı, Türkiye, 30 Kasım - 06 Aralık 2018, (Özet Bildiri)

13. Fasioscapulohumeral Kas Distrofisinde (FSHD) östrojenin B-katenin, DUX4 ve PAX3/7 düzeylerine etkisi

HANGÜL C.

13. Ulusal Tıbbi Genetik Kongresi, Antalya, Türkiye, 7 - 11 Kasım 2018, ss.148, (Özet Bildiri)

14. Fasioskapulahumeral musküler distrofi ve trombosiztoz birlikteliği

HANGÜL C., UYSAL H., YÜCEL O. K., TOYLU A., KARAÜZÜM S.

53. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 24 - 30 Kasım 2017, ss.1, (Özet Bildiri)